Trial intelligence / Profile preview

AA4500 in Advanced Dupuytren's Disease

NCT00528840Phase 3Completed

Sponsor
Endo International plc
Start
Oct 2007
Primary completion
Oct 2008
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of collagenase clostridium histolyticum in Dupuytren's disease, sponsored by Endo International plc. Started Oct 2007; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's disease

Beyond the preview

Go deeper on NCT00528840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00528840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call